Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Rheumatology
•
Osteoporosis
Is elevated bone specific alkaline phosphatase an absolute contraindication to teriparatide?
Related Questions
Are there any concerns with using denosumab in a patient with chronic hepatitis B infection on antiviral therapy?
What treatment options would you consider for a young patient with limited mobility, low bone mass and multiple vertebral compression fractures who is on dialysis for advanced kidney disease?
Is it safe to combine Prolia with other immunosuppressants?
Which fracture sites outside of the classical spine and hip are considered to be osteoporotic fractures even in the absence of a bone density diagnosis?
How do you manage hepatotoxicity thought to be related to Romosozumab use?
How should we interpret DXA scans in patients with Ankylosing Spondylitis who have ankylosis of the spine?
How do you approach using DMARDs for patients with CPP arthritis who have frequent flares?
Would you switch azathioprine to a different immunosuppressant if a controlled patient with SLE develops melanoma and/or non-melanoma skin cancer?
What is your approach to management of patients with recurrent nephrolithiasis and osteoporosis who are receiving teriparatide?
What features on CTA/MRA are most helpful for differentiating large vessel vasculitis from atherosclerosis?
